Otsuka loses lawsuit challenging FDA approval of generic Abilify
 

Otsuka loses lawsuit challenging FDA approval of generic Abilify
(Reuters) - Otsuka Pharmaceutical Co Ltd has lost a lawsuit challenging the U.S. Food and Drug Administration's decision to allow generic versions of the company's antipsychotic drug Abilify.http://i0.wp.com/reuters.us.feedspor...f?resize=1%2C1
http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...r4:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...r4:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/4Yjd3dI9a3U